Clinical manifestations, accompanying diseases, complications, and thymus pathologies in 102 patients with myasthenia gravis

Journal of Research in Medical Sciences

Volumn 11, Issue 1, 2006, Pages 63-66

  Vakilian, A R ^a   Shafa, M A ^b   Ahmady Kahnali, J ^a   Rismanchian, M ^b  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Accompanying diseases; Kerman; Myasthenia gravis; Osserman classification; Thymus pathology

Indexed keywords

ADULT; ARTICLE; CHI SQUARE TEST; CLINICAL FEATURE; DESCRIPTIVE RESEARCH; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GENDER; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; ONSET AGE; RESPIRATORY TRACT DISEASE; STUDENT T TEST; THYMOMA; THYMUS ATROPHY; THYMUS DISEASE; THYMUS HYPERPLASIA;

EID: 33748336476     PISSN: 17351995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Lefvert AK, Bergstrom K, Matell G, Osterman PO, Pirskanen R. Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications. J Neurol Neurosurg Psychiatry. 1978;41(5):394-403
2. Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology. 1976;26(11):1054-9.
3. Vincent A, Newsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry. 1985;48(12):1246-52.
4. Darchman DB. Myasthenia gravis. N Engl J Med 1994;330(25):1797-810.
5. Oosterhuis HJ, editor. Myasthenia Gravis (Clinical Neurology and Neurosurgery Monographs, Vol 5). London: Churchill Livingstone, 1984. p.27-8.
6. Grob D, Brunner NG, Namba T. The natural course of myasthenia gravis and effect of therapeutic measures. Ann N Y Acad Sci. 1981;377:652-69.
7. Somnier FE, Keiding N, Paulson OB. Epidemiology of myasthenia gravis in denmark. A longitudinal and comprehensive population survey. Arch Neurol. 1991;48(7):733-9.
8. Victor M, Ropper A, editors. Adams and victor principles of neurology. 7th ed. New York: McGraw-Hill; 2001. p.1536-50.
9. Sunders D, Howard J. Disorder of neuromuscular transmission. In: Walter GB, Robert BD, Gerald MF, editors. Neurology in clinical practice. 3rd ed. USA: Butter Worth Heinemann; 2000. p.2167-85.
10. Aarli JA, Romi F, Skeie GO, Gilhus NE. Myasthenia gravis in individuals over 40. Ann N Y Acad Sci. 2003;998:424-31.
11. Kalb B, Matell G, Pirskanen R, Lambe M. Epidemiology of myasthenia gravis: a population based study in stockholm, sweden. Neuroepidemiology. 2002;21(5):221-5.
12. Mantegazza R, Baggi F, Antozzi C, Confalonieri P, Morandi L, Bernasconi P, et al. Myasthenia gravis (MG): epidemiological data and prognostic factors. Ann N Y Acad Sci. 2003;998:413-423.
13. O'Riordan JI, Miller DH, Mottershead JP, Hirsch NP, Howard RS. The management and outcome of patients with myasthenia gravis treated acutely in a neurological intensive care unit. Eur J Neurol. 1998;5(2):137-142.
14. Tellez-Zenteno JF, Remes-Troche JM, Mimenza-Alvarado A, Garcia-Ramos GB, Vega-boada F. The association of myasthenia gravis and connective tissue diseases. Effects of thymectomy in six cases with rheumatoid arthritis and one case with systemic lupus erythematosus. Neurologia. 2003;18(2):54-8.
15. Togha M, Harirchian MH, Parchebaf N. survey of myasthenia gravis crisis in patients admitted to Imam Khomaini and Sina hospitals during 1370-1379. Iranian journal of neurology. 1381;2(5):105-6.